World Heart to appeal judgement on Abiomed "theft"
This article was originally published in Clinica
Executive Summary
Two of the companies racing to build the first permanent implantable mechanical heart replacement device have ended a two-year patent infringement case concerning a component technology. World Heart, a Canadian company, brought an action in 1998 claiming that Abiomed, of Danvers, Massachusetts, had stolen intellectual property rights in "skin transformer" technology, a method of transmitting energy across intact skin to power implantable devices.